Skip to main content
. 2015 Apr 15;99(10):1341–1344. doi: 10.1136/bjophthalmol-2015-306636

Table 1.

Mean choroidal thickness in pretreated and treatment-naive patients prior to and after a loading dose of three 2 mg aflibercept injections at 4 weeks interval

Retinal area Pretreated patients mean choroidal thickness Treatment-naive patients mean choroidal thickness
Before After p Value Before After p Value
2500NCT 112.4±49.7 104.8±49.4 <0.001 125.3±52.1 110.0±41.2 <0.001
300NCT 173.7±58.2 164.9±56.8 <0.001 218.7±69.2 196.3±71.2 <0.001
SFCT 182.8±57.4 172± 57.7 <0.001 226.4±68.5 208.0±66.6 <0.001
300TCT 173.6±57.5 163.7±56.2 <0.001 225.7±71.1 209.3±68.8 <0.001
2500TCT 176.2±55.1 165.5±54.6 <0.001 213.9±71.3 195.7±78.5 <0.001

2500NCT=choroidal thickness 2500 µm nasal from the central fovea, 300NCT=choroidal thickness 300 µm nasal from the central fovea, SFCT=subfoveal choroidal thickness, 300TCT=choroidal thickness 300 µm temporal from the central fovea, 2500TCT=choroidal thickness 2500 µm temporal from the central fovea.

Data presented as mean±SD.